Studying Protein Markers in Gum Disease at Different Stages
What is this trial?
This study is looking at two specific proteins (Gas6 and sMerTK) in gum fluid and blood to see if they differ between people with healthy gums, mild gum disease (gingivitis), and more advanced gum disease (periodontitis). By comparing these protein levels across different gum health stages, researchers hope to better understand how gum disease develops and potentially find new ways to diagnose or treat it.
Gum disease affects millions of people, but doctors don't yet have reliable biological markers to easily detect it early or track its progress. This study is investigating whether measuring specific proteins in gum fluid could serve as an early warning sign or help doctors better understand what's happening in diseased gums at a cellular level.
Do you qualify?
You likely qualify if…
- you are at least 18 years old
- you have at least 16 natural teeth (not counting wisdom teeth)
- you don't have serious health conditions like heart disease, diabetes, rheumatoid arthritis, or HIV
- you have not taken antibiotics in the last 3 months
- you are not currently taking medications that affect gum health
- you have not had professional gum treatment in the last 6 months
You likely don't qualify if…
- you are pregnant or breastfeeding
- you currently smoke cigarettes
- you have a history of infectious diseases like HIV, hepatitis B, or tuberculosis
- you have taken antibiotics within the past 3 months
- you have received periodontal (gum) treatment in the last 6 months
What participation looks like
As a participant, you would be placed into one of three groups based on your gum health: healthy gums, gingivitis (mild gum disease), or periodontitis (advanced gum disease). During your visit, the research team will measure your gums using standard clinical tools, then collect small samples of fluid from around your teeth and a blood sample. These samples will be tested in the lab to measure the protein levels being studied. The study appears to involve one main visit, though the exact timeline and number of visits is not specified in the trial details.
AI-generated summary from trial data · Apr 17, 2026 · Not medical advice
Trial locations(1 site)
Turkey (Türkiye)